|
|
Clinical Trials
Clinical Trials
A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn’s Disease (GSK1605786A)
Keywords: Gastrointestinal Diseases, Crohn's Disease | A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of PF-00547659 in Subjects with Crohn's Disease who are Anti-TNF Inadequate Responders (OPERA)
Keywords: Crohn's Disease | A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of Multistem (PF-05285401) in Subjects with Moderate to Severe Ulcerative Colitis (PF-05285401)
Keywords: Ulcerative Colitis. | A Phase 2, Randomized, Double-Blind, Place-Controlled Study to Evaluate the Safety and Efficacy of Filibuvir Plus Pegylated Interferon Alfa-2a and Ribavirin in Treatment naïve, HCV Genotype 1 Infected Subjects (A8121014)
Keywords: Liver Disease, Hepatitis C | A Phase 3, Open-label Study to Determine the Long-Term Safety and Efficacy of Vedolizumab (MLN0002) in Patients with Ulcerative Colitis and Crohn's Disease (Protocol Number C13008)
Keywords: GI Disorder, Ulcerative colitis, crohn’s disease | A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients with Moderate to Severe Crohn's Disease (Protocol C13007)
Keywords: GI Disorder, Crohn’s disease | A Randomised, Double-blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to-Severely Active Crohn's Disease
Keywords: Crohn's Disease | An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn’s Disease
Keywords: Gastrointestinal Disease, Crohn's Disease | Boceprevir and Peginterferon/Ribavirin for the Treatment of Chronic Hepatitis C in Treatment-Naive Subjects: A Comparison of Erythropoietin Use Versus Ribavirin Dose Reduction for the Management of Anemia (Protocol No. P06086)
Keywords: Liver Disease, HCV, Hepatitis C | HALO Patient Registry Ablation of Barrett's Esophagus
Keywords: GI Disorder, Barrett's esophagus, BE, HALO | Open-Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel In Subjects With Advanced Parkinson's Disease And Severe Motor-Fluctuations Who Have Exhibited A Persistent and Positive Effect To Treatment In Previous Studies
Keywords: Advanced Parkinson's Disease | Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects (S187.3.003)
Keywords: Idiopathic Parkinson's Disease, PD | Open-Label, 6-12 Months Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations (S187.3.004)
Keywords: Parkinson’s Disease, Levodopa-Carbidopa Intestinal Gel | Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing REMICADE® (infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence (PREVENT)
Keywords: Crohn's Disease |
All Research
A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn’s Disease (GSK1605786A)
Keywords: Gastrointestinal Diseases, Crohn's Disease | A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of PF-00547659 in Subjects with Crohn's Disease who are Anti-TNF Inadequate Responders (OPERA)
Keywords: Crohn's Disease | A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of Multistem (PF-05285401) in Subjects with Moderate to Severe Ulcerative Colitis (PF-05285401)
Keywords: Ulcerative Colitis. | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study To Assess The Safety and Efficacy of VP 20621 For Prevention of Recurrence of Clostridium Difficile Infection (CDI) In Adults Previously Treated For CDI
Keywords: Clostridium difficile infection, | A Phase 2, Randomized, Double-Blind, Place-Controlled Study to Evaluate the Safety and Efficacy of Filibuvir Plus Pegylated Interferon Alfa-2a and Ribavirin in Treatment naïve, HCV Genotype 1 Infected Subjects (A8121014)
Keywords: Liver Disease, Hepatitis C | A Phase 3, Open-label Study to Determine the Long-Term Safety and Efficacy of Vedolizumab (MLN0002) in Patients with Ulcerative Colitis and Crohn's Disease (Protocol Number C13008)
Keywords: GI Disorder, Ulcerative colitis, crohn’s disease | A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients with Moderate to Severe Crohn's Disease (Protocol C13007)
Keywords: GI Disorder, Crohn’s disease | A Prospective Study Quantitating Fecal TNF-Alpha In Active IBD Compared to Other Forms of Acute Enterocolitis
Keywords: GI Disease, Inflammatory Bowel Disease, IBD, Chrohn’s disease | A Randomised, Double-blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to-Severely Active Crohn's Disease
Keywords: Crohn's Disease | A Randomized, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly with Peginterferon alfa-2b and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 Hepatitis C Virus Infection
Keywords: | An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn’s Disease
Keywords: Gastrointestinal Disease, Crohn's Disease | Boceprevir and Peginterferon/Ribavirin for the Treatment of Chronic Hepatitis C in Treatment-Naive Subjects: A Comparison of Erythropoietin Use Versus Ribavirin Dose Reduction for the Management of Anemia (Protocol No. P06086)
Keywords: Liver Disease, HCV, Hepatitis C | Gastroparesis in Cirrhosis
Keywords: Cirrhosis, Gastroparesis, Delayed Gastic Emptying | HALO Patient Registry Ablation of Barrett's Esophagus
Keywords: GI Disorder, Barrett's esophagus, BE, HALO | Open-Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel In Subjects With Advanced Parkinson's Disease And Severe Motor-Fluctuations Who Have Exhibited A Persistent and Positive Effect To Treatment In Previous Studies
Keywords: Advanced Parkinson's Disease | Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects (S187.3.003)
Keywords: Idiopathic Parkinson's Disease, PD | Open-Label, 6-12 Months Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations (S187.3.004)
Keywords: Parkinson’s Disease, Levodopa-Carbidopa Intestinal Gel | Prevalence of Elevated Right Ventricular Systolic Pressures in Patients with Hepatitis C-Related Cirrhosis at a Non-Liver Transplant Center
Keywords: Liver Disease, Hepatitis C, Cirrhosis | Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing REMICADE® (infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence (PREVENT)
Keywords: Crohn's Disease | Retrospective Comparison of Endoscopic Ultrasound Guided Fine Needle Aspiration with Trucut Needle Biopsy in Patients with Gastrointestinal Masses
Keywords: GI Disease, Trucut needle, FNA | The Use of Self-Expanding Metal Stents for Treatment of Acute Colonic Obstruction: A Clinical Case Series
Keywords: | Unusual Objects Removed From Unusual Patients: A Case Series and Literature Review
Keywords: Foreign body removal |
|
Health Encyclopedia
For more information, please visit our Multimedia Health Encyclopedia:
|
